Loading company…
VascVersa develops cell therapies for vascular regeneration.
Founded in 2018 and based in Belfast, Ireland, VascVersa develops regenerative medicine products. Its ANGICYTE™ technology is designed to support cell therapies that regenerate tissue, including potential treatments for diabetic foot ulcers. In May 2021, the company raised GBP 500,000 in seed funding from QUBIS Limited, Halo Business Angel Network, and Co-FundNI.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in